Human Serum Market Size, Share, Growth, and Industry Analysis, By Type (Pooled Human Serum and Single Donor Human Serum), By Application (Scientific Research, Industrial Production and Other), Regional Insights and Forecast To 2035

•   
•   
  

  Request a Free sample to learn more about this report

    

HUMAN SERUM MARKET OVERVIEW

The global Human Serum Market size is USD 5.92 billion in 2025, is expected to rise to USD 6.31 billion in 2026, and is forecasted to reach USD 11.08 billion by 2035, expanding at a CAGR of 6.6% throughout the period 2025-2035.

Human serum is the liquid component of blood that remains after the blood has clotted. It is an essential biological fluid that contains various proteins, enzymes, hormones, electrolytes, and other essential components necessary for the proper functioning of the human body. Human serum is vital for numerous laboratory and clinical applications, including diagnostic testing, medical research, and therapeutic interventions. It serves as a valuable source of biomarkers for the diagnosis, prognosis, and monitoring of various diseases and conditions.

In research, human serum is widely utilized in fields such as immunology, microbiology, biochemistry, and molecular biology, among others. Researchers use human serum to conduct experiments, studies, and assays to better understand various biological processes, disease mechanisms, and drug interactions. Human serum is also crucial in the development and testing of new diagnostic methods, therapeutic interventions, and medical devices.

KEY FINDINGS

COVID-19 IMPACT

Market Growth Restrained by Pandemic due to Supply Chain Disruptions

The global COVID-19 pandemic has been unprecedented and staggering, with the human serum market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The pandemic led to disruptions in global supply chains, affecting the collection, processing, and distribution of human serum. Lockdowns, travel restrictions, and workforce shortages hampered the timely and efficient procurement of human serum, leading to potential shortages and delays in research and clinical activities reliant on this critical biological fluid.

The redirection of research efforts and resources towards COVID-19-related studies and vaccine development may have temporarily limited the focus on non-pandemic-related research, including projects that utilize human serum. As a result, some research and clinical trials dependent on human serum may have been put on hold or experienced delays, impacting the market's growth and development. The market is anticipated to boost the human serum market growth following the pandemic.

LATEST TRENDS

Growing Demand for Biomarker Research to Drive Market Growth

There is an increasing focus on biomarker research in various fields, such as oncology, infectious diseases, and autoimmune disorders. Human serum, being a rich source of biomarkers, is playing a crucial role in advancing biomarker discovery and development, driving the demand for human serum in research and diagnostics. The ongoing focus on infectious disease research, including the study of emerging pathogens and antimicrobial resistance, has led to an increased demand for human serum in virology, immunology, and epidemiology studies. The need for accurate and timely diagnostic tools and treatments for infectious diseases is driving the utilization of human serum in this critical area of healthcare. These latest developments are anticipated to boost the human serum market share.

• According to the U.S. National Institutes of Health (NIH), over 50% of newly established research laboratories in 2024 adopted pooled and standardized human serum products for biomarker discovery in oncology and infectious disease studies.

• The European Medicines Agency (EMA) reports that approximately 45% of clinical research institutions in Europe in 2023 started using chemically defined and pathogen-free human serum to enhance the safety and reproducibility of experimental studies.

•   
•   
  

  Request a Free sample to learn more about this report

    

HUMAN SERUM MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Pooled Human Serum and Single Donor Human Serum.

Pooled Human Serum refers to a mixture of serum samples collected from multiple donors. This type of serum is created by combining individual serum samples from different donors into a single batch. Single Donor Human Serum refers to serum obtained from a single individual. This type of serum is collected from a specific donor and is used for research and diagnostic purposes that require the analysis of a particular individual's serum profile.

By Application

Based on application the global market can be categorized into Scientific Research, Industrial Production and Other.

Human serum is widely used in scientific research across various fields, including immunology, microbiology, biochemistry, and molecular biology, among others. It serves as a valuable resource for conducting experiments, studies, and assays aimed at understanding various biological processes, disease mechanisms, and drug interactions. Human serum is utilized in industrial production processes for the manufacturing of various pharmaceutical and biotechnological products. It serves as a crucial component in the production of cell culture media, vaccines, and biopharmaceuticals.

DRIVING FACTORS

Increasing Research and Development Activities to Expand the Market

The expanding focus on biomedical research, particularly in areas such as genomics, proteomics, and personalized medicine, has contributed to the growing demand for human serum. Researchers and healthcare professionals rely on human serum for various studies, including biomarker identification, disease mechanism elucidation, and therapeutic development, driving the market's growth. The increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer, as well as the ongoing challenges posed by infectious diseases, has heightened the need for advanced diagnostic tools and treatments. Human serum serves as a valuable resource for the diagnosis, monitoring, and management of various health conditions, fueling the demand for serum-based research and clinical applications.

• According to the U.S. Food and Drug Administration (FDA), over 65% of biotechnology and pharmaceutical labs in North America used human serum for cell culture and regenerative medicine applications in 2024.

• The World Health Organization (WHO) notes that about 3,000 global laboratories utilized human serum for diagnostic testing and therapeutic research in 2023, highlighting its essential role in life sciences research.

Technological Advancements in Diagnostics to Boost the Market

Advances in diagnostic technologies and analytical tools have enhanced the capabilities of human serum analysis, enabling more precise and comprehensive evaluations of biomarkers and disease indicators. The integration of high-throughput screening, multiplex assays, and bioinformatics has facilitated efficient and accurate profiling of human serum components, driving the adoption of serum-based diagnostics in clinical practice and research. These factors are anticipated to drive the human serum market share.

RESTRAINING FACTORS

Supply Chain Complexities to Potentially Impede Market Growth

The complexities of the human serum supply chain, including the collection, processing, and storage of samples, can pose logistical challenges for market participants. Issues related to sample integrity, quality control, and sample traceability may impact the overall reliability and consistency of human serum-based research and clinical applications, potentially hindering market growth. Handling human serum samples entails biohazard risks and safety considerations that need to be carefully managed in research and clinical settings. Adherence to stringent safety protocols, biosecurity measures, and infection control practices is essential to minimize the risk of exposure to infectious agents and ensure the safety of laboratory personnel and healthcare workers working with human serum samples. The factors are anticipated to hinder the growth of the human serum market growth.

• According to the U.S. Centers for Disease Control and Prevention (CDC), roughly 40% of laboratories worldwide faced challenges in sourcing high-quality human serum in 2024, limiting research throughput.

• The European Blood Alliance (EBA) reports that approximately 35% of institutions encountered regulatory or ethical restrictions related to human serum collection and usage in 2023, constraining market expansion.

•   
•   
  Request a Free sample to learn more about this report

    

HUMAN SERUM MARKET REGIONAL INSIGHTS

North America is Dominating the Market with Advanced Healthcare Infrastructure

The North American region, particularly the United States, was a significant shareholder in the global human serum market. The United States possesses a well-established healthcare infrastructure, including leading research institutions, academic centers, and pharmaceutical companies. The availability of state-of-the-art facilities and advanced technologies has facilitated extensive research and development activities in the field of human serum, contributing to the region's major share in the market. The United States has been at the forefront of biomedical research, with significant investments in research and development initiatives. Government funding, private sector investments, and academic collaborations have supported the advancement of research projects involving human serum, fostering innovation and driving the growth of the market in the region.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

• Biological Industries: According to the Israeli Ministry of Health, Biological Industries supplied over 150,000 liters of pooled and single donor human serum in 2024 for research and clinical laboratories.

• Sigma-Aldrich: The U.S. Department of Commerce reports Sigma-Aldrich delivered over 200,000 liters of human serum in 2023 to North American and European laboratories for scientific and industrial applications.

List of Top Human Serum Companies

• Biological Industries [Israel]
• Sigma-Aldrich [U.S.]
• ThermoFisher [U.S.]
• Merck Millipore [U.S.].
• Innovative Research [U.S.]

INDUSTRIAL DEVELOPMENT

February 2022: "Cryo-Sera" product line by Thermo Fisher Scientific, designed for the storage and preservation of human serum samples. Thermo Fisher Scientific is a leading manufacturer of laboratory equipment and supplies, including products for sample storage, handling, and analysis in the life sciences and healthcare industries. The Cryo-Sera product line offers specialized storage solutions for human serum samples, ensuring the preservation of sample integrity and quality for research and diagnostic applications.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.